COMPARE: Pharmacokinetic profiles of subcutaneous peginterferon beta‐1a and subcutaneous interferon beta‐1a over 2 weeks in healthy subjects

por Hu, Xiao, Shang, Shulian, Nestorov, Ivan, Hasan, Jawad, Seddighzadeh, Ali, Dawson, Katherine, Sperling, Bjørn, Werneburg, Brian
Publicado 2016

Population‐Based Pharmacokinetic and Exposure‐Efficacy Analyses of Peginterferon Beta‐1a in Patients With Relapsing Multiple Sclerosis

por Hu, Xiao, Hang, Yaming, Cui, Yue, Zhang, Jie, Liu, Shifang, Seddighzadeh, Ali, Deykin, Aaron, Nestorov, Ivan
Publicado 2017

Pharmacokinetics, Pharmacodynamics, and Safety of Peginterferon Beta-Ia in Subjects with Normal or Impaired Renal Function

por Hu, Xiao, Seddighzadeh, Ali, Stecher, Scott, Zhu, Ying, Goyal, Jaya, Matson, Mark, Marbury, Thomas, Smith, William, Nestorov, Ivan, Hung, Serena
Publicado 2015

Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE

por Kieseier, Bernd C, Arnold, Douglas L, Balcer, Laura J, Boyko, Alexey A, Pelletier, Jean, Liu, Shifang, Zhu, Ying, Seddighzadeh, Ali, Hung, Serena, Deykin, Aaron, Sheikh, Sarah I, Calabresi, Peter A
Publicado 2015